2.95

5.79% -0.17

Xenetic Biosciences Inc (XBIO)

Overview News Price History Financials Discussions Forecast Stock Split

Xenetic Biosciences Inc stock is traded at $2.95, with a volume of 47,574. It is down -5.79% in the last 24 hours and down -9.84% over the past month. Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Previous Close:

$3.12

Open:

$3.08

24h Volume:

47,574

Relative Volume:

0.06

Market Cap:

$4.58M

Revenue:

$2.54M

Net Income/Loss:

$-4.13M

P/E Ratio:

-1.0727

EPS:

-2.75

Net Cash Flow:

$-4.11M

1W Performance:

-17.90%

1M Performance:

-9.84%

6M Performance:

+6.11%

1Y Performance:

-19.75%

1-Day Range:

$2.92

$3.12

1-Week Range:

$2.92

$3.62

52-Week Range:

$2.20

$13.93

Xenetic Biosciences Inc Stock (XBIO) Company Profile

Name

Xenetic Biosciences Inc

Sector

Healthcare (1140)

Industry

Biotechnology (633)

Phone

781-778-7720

Address

945 CONCORD ST., FRAMINGHAM, MA

Employee

Twitter

@XeneticBio

Next Earnings Date

2024-11-07

Latest SEC Filings

XBIO's Discussions on Twitter

Compare XBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XBIO Xenetic Biosciences Inc	2.969	7.10M	2.54M	-4.13M	-4.11M	-2.75
VRTX Vertex Pharmaceuticals Inc	424.67	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	631.49	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	425.97	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	838.79	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	184.66	39.72B	447.02M	-1.18B	-868.57M	-6.1812

Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-20	Initiated	Maxim Group	Buy

Xenetic Biosciences Inc Stock (XBIO) Latest News

04:52 AM

Is Xenetic Biosciences Inc. stock bottoming outWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - newser.com

04:52 AM

04:46 AM

Detecting support and resistance levels for Xenetic Biosciences Inc.Quarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com

04:46 AM

04:37 AM

Is Xenetic Biosciences Inc. (3XB0) stock bottoming after sell offCPI Data & Stock Market Timing Techniques - newser.com

04:37 AM

03:24 AM

Will Xenetic Biosciences Inc. stock split attract more investorsJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com

03:24 AM

03:14 AM

Why Xenetic Biosciences Inc. is moving todayJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com

03:14 AM

02:22 AM

Best data tools to analyze Xenetic Biosciences Inc. stockGDP Growth & Technical Entry and Exit Alerts - newser.com

02:22 AM

Nov 03, 2025